CD8A and infectious disease: Because IDO is known to suppress T-cell-mediated adaptive immune responses in a range of clinically relevant syndromes, including autoimmune, allergic, and infectious diseases [9, 10], we also evaluated CD4+ and CD8+ T-cell responses specific for JEV antigen in surviving BL/6 and IDO-ablated mice 7 dpi.